Israel Active

The new Israeli-developed Microclimate Suit is successfully eliminating congestion in heart failure patients at Israel’s Rambam hospital. It evaporates body fluids, alleviating symptoms of heart failure by reducing the level of the stress hormone BNP (B-type natriuretic peptide) by up to 50%.

Israeli doctors regularly treat eye diseases in Africa (see and previously). Sheba Medical Center has now launched a humanitarian mission to Ilorin, Nigeria to treat eye-cancer in children and improve long-term quality optical care, by establishing an intra-arterial chemotherapy center.

Nine Israeli startups have been selected for Google for Startups’ first Growth Academy program for startups in the fields of medicine and quality of life. They are Olive Diagnostics, Kai, Emble, Droxi, BoBo Balance, Agado Live, AIVF, X-Trodes, and Ritual Health Technologies.

IsraelActive.com (see ) contains over a dozen articles describing how Israeli medical clowns help hospital patients. Now Tel Aviv University researchers have documented 40 different skills that the clowns deploy to enable patients to overcome crises and move towards healing.

When a nine-year-old Israeli girl lost a tooth, she accidentally sucked it into her lung, blocking her airway – a medical and life-threatening emergency. Doctors at Haifa’s Rambam Pediatric Emergency Trauma Unit became “tooth fairies” and used a guided camera to pull the tooth from her lung.

Three years ago, one of a group of Israeli cyclists died when he had a heart attack, miles from the nearest hospital. Since then, the group carries a portable defibrillator on all trips. It recently saved the life of another member of the group, who suffered cardiac arrest in the Negev desert.

Since its first trial in 2019, Israel’s Active Implants (see previously) has performed nearly 1,000 implants of its NUsurface synthetic meniscus in Israel and Europe. It expects FDA approval to allow launch in the US in 2024.

Latest on the ART device of Israel’s Inspira Technologies (see previously) to instantly boost oxygen levels of patients having trouble breathing, reducing the need to induce comas and place them on ventilators. The machine removes low oxygen blood from the body, adds oxygen, removes CO2, and returns it to the patient.

Scientists at Jerusalem’s Hadassah hospital and Bar-Ilan University have developed HBI0101- a CAR-T therapy for multiple myeloma and amyloidosis, benefiting over 90% of patients in trials. Los Angeles-based Immix BioPharma will commercialize HBI0101.

A team from Magen David (MDA) and three Israeli hospitals are currently in Addis Ababa, Ethiopia training doctors and nurses in the treatment of trauma. In a separate mission, Professor Hanoch Kashtan and his Assuta Ashdod team have been training surgeons and nurses, in northern Ethiopia.